Provectus Biopharmaceuticals Inc (PVCT)
0.19
+0.01
(+6.26%)
USD |
OTCM |
May 08, 14:57
Provectus Biopharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2006 | 0.0235 |
| September 30, 2006 | 0.0341 |
| June 30, 2006 | 0.0334 |
| March 31, 2006 | 0.0516 |
| December 31, 2005 | 0.0611 |
| September 30, 2005 | 0.187 |
| June 30, 2005 | 0.2192 |
| March 31, 2005 | 0.2013 |
| December 31, 2004 | 0.1827 |
| September 30, 2004 | 0.1381 |
| June 30, 2004 | 0.0863 |
| March 31, 2004 | 0.0743 |
| Date | Value |
|---|---|
| December 31, 2003 | 0.1147 |
| September 30, 2003 | 0.0625 |
| June 30, 2003 | 0.0568 |
| March 31, 2003 | 0.0539 |
| December 31, 2002 | 0.0495 |
| September 30, 2002 | -0.135 |
| June 30, 2002 | -0.1993 |
| March 31, 2002 | 0.00 |
| December 31, 2001 | -0.5763 |
| September 30, 2001 | -1.00 |
| June 30, 2001 | |
| March 31, 2001 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Insmed Inc | -3.481 |
| NeuroMetrix Inc | 0.00 |
| Intra-Cellular Therapies Inc | 0.00 |
| Rhythm Pharmaceuticals Inc | 0.00 |
| Amylyx Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.449M |
| Total Liabilities (Quarterly) | 9.042M |
| Shareholders Equity (Quarterly) | -7.593M |